‘If it were me, I wouldn’t conduct the BCG vaccine trials on sr. citizens,’ says Dr. Navaneetha Rao

Covixin - India’s first indigenous Covid vaccine

Speaking to the Federal about Tamil Nadu government’s decision to study the BCG vaccine’s efficacy in senior citizens, scientist Dr. Navaneetha Rao says he wouldn’t conduct the study and gives advice against it. He also talks about how resources need to be optimally used with the increasing COVID cases. Listen to The Federal podcast to get more insights.

AdvertisementChoco-pie Ad
Get breaking news and latest updates from India
and around the world on thefederal.com